TABLE 1.
Subject no. | Sample no. | Sample day | MIC(s) (μg/ml) | Mutation(s) in:
|
OSTd | PFGE pattern(s) | |
---|---|---|---|---|---|---|---|
gyrA | parC | ||||||
1 | 1 | 0 | 70.25 | A87T | None | Neg | A |
2 | 28 | 0.25 | A87T | None | Pos | A | |
3 | 41 | Neg | |||||
4 | 57 | Neg | |||||
5 | |||||||
6 | |||||||
7 | |||||||
8 | |||||||
9 | |||||||
10 | |||||||
2 | 1 | 0 | 0.5 | S83L | Neg | Neg | B |
2 | 58 | Neg | |||||
3 | 71 | Neg | |||||
4 | 85 | Neg | |||||
5 | 99 | Neg | |||||
6 | 119 | Neg | |||||
7 | 176 | Neg | |||||
8 | |||||||
9 | |||||||
10 | |||||||
3 | 1 | 0 | 32 | S83L, D87G | S80I | Pos | C |
2 | 17 | Neg | |||||
3 | 28 | Neg | |||||
4 | 44 | Neg | |||||
5 | 57 | 32 | S83L, D87G | S80I | Pos | C | |
6 | 71 | Neg | |||||
7 | 85 | 32 | S83L, D87G | S80I | C | ||
8 | 100 | Neg | |||||
9 | 128 | 0.064 | Neg | Neg | Pos | D | |
10 | 156 | Neg | |||||
4 | 1 | 0 | 0.19 | Neg | Neg | Neg | E |
2 | 17 | Neg | |||||
3 | 35 | Neg | |||||
4 | 45 | Neg | |||||
5 | 60 | Neg | |||||
6 | 72 | Neg | |||||
7 | 92 | Neg | |||||
8 | 102 | 0.064 | Neg | Neg | Neg | E | |
9 | 140 | Neg | |||||
10 | 178 | Neg | |||||
5 | 1 | 0 | >32 | S83L, D87T | S83L, D87T | Pos | F |
2 | 17 | >32 | S83L, D87T | S83L, D87T | Pos | F | |
3 | 29 | >32 | S83L, D87T | S83L, D87T | Pos | F | |
4 | 38 | >32 | S83L, D87T | S83L, D87T | Pos | F | |
5 | 58 | >32 | S83L, D87T | S83L, D87T | Pos | F | |
6 | 71 | >32 | S83L, D87T | S83L, D87T | Pos | F | |
7 | 85 | >32 | S83L, D87T | S83L, D87T | Pos | F | |
8 | 112 | >32 | S83L, D87T | S83L, D87T | Pos | F | |
9 | 139 | >32 | S83L, D87T | S83L, D87T | Pos | F | |
10 | 167 | >32 | S83L, D87T | S83L, D87T | Pos | F | |
6 | 1 | 0 | 32 | S83L, D87D | S80I, G84V | Pos | NT |
2 | 12 | 32 | S83L, D87D | S80I, G84V | Pos | NT | |
3 | 27 | 32/32b | S83L, D87D | S80I, G84V | Neg/neg | NT | |
4 | 41 | 32 | S83L, D87D | S80I, G84V | Pos | NT | |
5 | 56 | 32 | S83L, D87D | S80I, G84V | Neg | NT | |
6 | 70 | Neg | |||||
7 | 83 | 32 | S83L, D87D | S80I, G84V | Pos | NT | |
8 | 134 | Neg | |||||
9 | 153 | 32 | S83L, D87D | S80I, G84V | Pos | NT | |
10 | |||||||
gyrA | parC | ||||||
7 | 1 | 0 | 0.25 | D87T | Neg | Neg | G |
2 | 12 | 0.25 | D87T | Neg | Neg | G | |
3 | 26 | Neg | |||||
4 | 41 | Neg | |||||
5 | 56 | Neg | |||||
6 | 70 | 0.25 | D87T | Neg | Neg | G | |
7 | 84 | 0.25 | D87T | Neg | Neg | G | |
8 | 106 | 0.38 | D87T | Neg | Neg | G | |
9 | 132 | NA | NA | NA | NA | NA | |
10 | 162 | 0.19 | D87T | Neg | Neg | G | |
8 | 1 | 0 | 0.19 | Neg | Neg | Pos | H |
2 | 28 | Neg | |||||
3 | 37 | 0.38 | Neg | Neg | Pos | H | |
4 | 51 | 0.25 | Neg | Neg | Pos | H | |
5 | 65 | 0.125 | Neg | Neg | Pos | H | |
6 | 79 | 0.125 | Neg | Neg | Pos | H | |
7 | 94 | 0.19 | Neg | Neg | Pos | H | |
8 | 107 | 0.19 | Neg | Neg | Pos | H | |
9 | 141 | Neg | |||||
10 | 177 | Neg | |||||
9 | 1 | 0 | >32 | S83L, D87N | S80I | Pos | I |
2 | 21 | >32 | S83L, D87N | S80I | Pos | I | |
3 | 34 | 0.5 | S83L | Neg | Neg | J | |
4 | 50 | 0.5 | S83L | Neg | Neg | J | |
5 | 64 | >32/0.5c | S83L, A87Nc | S80Ic | Pos/negc | I/J | |
6 | 92 | >32 | S83L, D87N | S80I | Pos | I | |
7 | 99 | 0.5 | S83L | Neg | Neg | J | |
8 | 112 | 0.19 | S83L | Neg | Neg | J | |
9 | 146 | >32 | S83L, D87N | S80I | Pos | I | |
10 | 173 | >32 | S83L, D87N | Neg | Pos | I | |
10 | 1 | 0 | 0.38 | D87N | Neg | Neg | K |
2 | 38 | 0.38 | D87N | Neg | Neg | K | |
3 | 53 | 0.38 | D87N | Neg | Neg | K | |
4 | 66 | 0.38 | D87N | Neg | Neg | NA | |
5 | 80 | 0.38 | D87N | Neg | Neg | K | |
6 | 95 | 0.25 | D87N | Neg | Neg | K | |
7 | 127 | 0.10 | D87N | Neg | Neg | K | |
8 | 148 | Neg | |||||
9 | |||||||
10 |
Sample no. 1 represents the final inpatient sample; sample day refers to the number of days after discharge the sample was obtained. There was no genetic relatedness of isolates across subjects. Neg, negative; Pos, positive; NA, not available; NT, not typeable.
Two strains identified differed only in that one strain had the noted parC mutations while the other strain had no parC mutations.
The MIC values, gyrA and parC mutations, and the OST findings were consistent with both previously identified strains in this patient.
OST, organic-solvent tolerance.